Takafumi Naito (Yasuaki Mino)

Researcher Name Resolver ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 22

Top Topics

Squamous Cell Carcinoma

Tandem Mass Spectrometry

Chemotherapy Induced

General Practice

Top Venues

European journal of clinical pharmacology

Cancer chemotherapy and pharmacology

Fundamental & clinical pharmacology

Journal of pharmaceutical health care and sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Hideki Kobayashi, Shugo Tohyama, Hajime Ichimura, Noburo Ohashi, Shuji Chino, Yusuke Soma, Hidenori Tani, Yuki Tanaka, Xiao Yang, Naoko Shiba, Shin Kadota, Kotaro Haga, Taijun Moriwaki, Yuika Morita-Umei, Tomohiko C Umei, Otoya Sekine, Yoshikazu Kishino, Hideaki Kanazawa, Hiroyuki Kawagishi, Mitsuhiko Yamada, Kazumasa Narita, Takafumi Naito, Tatsuichiro Seto, Koichiro Kuwahara, Yuji Shiba, Keiichi Fukuda
Regeneration of Nonhuman Primate Hearts With Human Induced Pluripotent Stem Cell-Derived Cardiac Spheroids. Circulation (2024)
Emi Nakatsugawa, Takafumi Naito, Kaito Shibata, Ryo Kitajima, Junichi Kawakami
Impacts of genetic polymorphisms and cancer cachexia on naldemedine pharmacokinetics and bowel movements in patients receiving opioid analgesics. Fundamental & clinical pharmacology (2024)
Emi Nakatsugawa, Takafumi Naito, Kaito Shibata, Ryo Kitajima, Junichi Kawakami
Impacts of genetic polymorphisms and cancer cachexia on naldemedine pharmacokinetics and bowel movements in patients receiving opioid analgesics. Fundamental & clinical pharmacology 38 (3) (2024)
Miho Terasawa, Kaito Shibata, Akira Mimura, Emi Nakatsugawa, Kazuhito Takahashi, Toshinori Nakamura, Tatsuya Saigusa, Takafumi Naito
Serum Profiles of Solifenacin and Interleukin-6 and Their Relationship With Psychiatric Symptoms in a Patient With Overactive Bladder Syndrome and Systemic Inflammation. Therapeutic drug monitoring (2024)
Hideki Kobayashi, Shugo Tohyama, Hajime Ichimura, Noburo Ohashi, Shuji Chino, Yusuke Soma, Hidenori Tani, Yuki Tanaka, Xiao Yang, Naoko Shiba, Shin Kadota, Kotaro Haga, Taijun Moriwaki, Yuika Morita-Umei, Tomohiko C Umei, Otoya Sekine, Yoshikazu Kishino, Hideaki Kanazawa, Hiroyuki Kawagishi, Mitsuhiko Yamada, Kazumasa Narita, Takafumi Naito, Tatsuichiro Seto, Koichiro Kuwahara, Yuji Shiba, Keiichi Fukuda
Regeneration of Nonhuman Primate Hearts With Human Induced Pluripotent Stem Cell-Derived Cardiac Spheroids. Circulation 150 (8) (2024)
Emi Nakatsugawa, Takafumi Naito, Kaito Shibata, Ryo Kitajima, Junichi Kawakami
Impacts of genetic polymorphisms and cancer cachexia on naldemedine pharmacokinetics and bowel movements in patients receiving opioid analgesics. Fundamental & clinical pharmacology 38 (3) (2024)
Yusuke Suzuki, Takafumi Naito, Kaito Shibata, Seiji Hosokawa, Junichi Kawakami
Associations of plasma aprepitant and its N-dealkylated metabolite with cachexia status and clinical responses in head and neck cancer patients. Cancer chemotherapy and pharmacology (2023)
Yusuke Suzuki, Takafumi Naito, Kaito Shibata, Seiji Hosokawa, Junichi Kawakami
Associations of plasma aprepitant and its N-dealkylated metabolite with cachexia status and clinical responses in head and neck cancer patients. Cancer chemotherapy and pharmacology 91 (6) (2023)
Yusuke Suzuki, Takafumi Naito, Kaito Shibata, Seiji Hosokawa, Junichi Kawakami
Associations of plasma aprepitant and its N-dealkylated metabolite with cachexia status and clinical responses in head and neck cancer patients. Cancer chemotherapy and pharmacology 91 (6) (2023)
Takafumi Naito, Takafumi Naito, Junya Ohshiro, Takahiro Yamada, Junichi Kawakami
Investigation of the boxed warnings in package inserts of prescription medicines for medical professionals in Japan. Pharmacy practice 20 (4) (2022)
Takafumi Naito, Takafumi Naito, Junya Ohshiro, Takahiro Yamada, Junichi Kawakami
Investigation of the boxed warnings in package inserts of prescription medicines for medical professionals in Japan. Pharmacy practice 20 (4) (2022)
Léa Bolcato, Charles Khouri, Anette Veringa, Jan Willem C Alffenaar, Takahiro Yamada, Takafumi Naito, Fabien Lamoureux, Xavier Fonrose, Françoise Stanke-Labesque, Elodie Gautier-Veyret
Combined Impact of Inflammation and Pharmacogenomic Variants on Voriconazole Trough Concentrations: A Meta-Analysis of Individual Data. Journal of clinical medicine 10 (10) (2021)
Kazuki Abe, Kaito Shibata, Takafumi Naito, Atsushi Otsuka, Masato Karayama, Masato Maekawa, Hideaki Miyake, Takafumi Suda, Junichi Kawakami
Impacts of cachexia progression in addition to serum IgG and blood lymphocytes on serum nivolumab in advanced cancer patients. European journal of clinical pharmacology (2021)
Kaito Shibata, Takafumi Naito, Satoshi Hirakawa, Koji Suzuki, Seiji Hosokawa, Hiroyuki Mineta, Junichi Kawakami
Correlations between serum cetuximab and EGFR-related markers, and skin disorders in head and neck cancer patients. Cancer chemotherapy and pharmacology 87 (4) (2021)
Tatsuya Yagi, Takafumi Naito, Ayami Kato, Kensho Hirao, Junichi Kawakami
Association Between the Prothrombin Time-International Normalized Ratio and Concomitant Use of Antibiotics in Warfarin Users: Focus on Type of Antibiotic and Susceptibility of Bacteroides fragilis to Antibiotics. The Annals of pharmacotherapy 55 (2) (2020)
Yumi Imoto, Takafumi Naito, Yukari Miyadera, Takaaki Ono, Junichi Kawakami
Associations between plasma hydroxylated metabolite of itraconazole and serum creatinine in patients with a hematopoietic or immune-related disorder. European journal of clinical pharmacology 77 (3) (2020)
Yumi Imoto, Yasuaki Mino, Takafumi Naito, Takaaki Ono, Junichi Kawakami
Simultaneous determination of itraconazole and its CYP3A4-mediated metabolites including N-desalkyl itraconazole in human plasma using liquid chromatography-tandem mass spectrometry and its clinical application. Journal of pharmaceutical health care and sciences 6 (2020)
Koji Suzuki, Takafumi Naito, Hironari Tanaka, Kaito Shibata, Yasuhide Yamada, Kunihiko Itoh, Junichi Kawakami
Impact of CYP2D6 activity and cachexia progression on enantiomeric alteration of plasma tramadol and its demethylated metabolites and their relationships with central nervous system symptoms in head and neck cancer patients. Basic & clinical pharmacology & toxicology 128 (3) (2020)
Shigeki Ikeya, Jun-Ichi Sakabe, Takahiro Yamada, Takafumi Naito, Yoshiki Tokura
Voriconazole-induced photocarcinogenesis is promoted by aryl hydrocarbon receptor-dependent COX-2 upregulation. Scientific reports 8 (1) (2018)
Hironari Tanaka, Takafumi Naito, Hikaru Sato, Takanori Hiraide, Yasuhide Yamada, Junichi Kawakami
Impact of CYP genotype and inflammatory markers on the plasma concentrations of tramadol and its demethylated metabolites and drug tolerability in cancer patients. European journal of clinical pharmacology 74 (11) (2018)
Hikaru Sato, Takafumi Naito, Takuya Ishida, Junichi Kawakami
Relationships between oxycodone pharmacokinetics, central symptoms, and serum interleukin-6 in cachectic cancer patients. European journal of clinical pharmacology 72 (12) (2016)
Hironari Tanaka, Takafumi Naito, Yasuaki Mino, Junichi Kawakami
Validated determination method of tramadol and its desmethylates in human plasma using an isocratic LC-MS/MS and its clinical application to patients with cancer pain or non-cancer pain. Journal of pharmaceutical health care and sciences 2 (2016)